CLASS II Drug recall · Reported 12 Dec 2012 · FDA Enforcement Report
Fluorouracil Topical Cream USP, 5% Tube recalled
Taro Pharmaceuticals U is recalling Fluorouracil Topical Cream USP, 5% Tube, distributed nationwide in the US. The recall was initiated on 21 Nov 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-086-2013
- FDA event ID
- 63685
- Recalling firm
- Taro Pharmaceuticals U, Hawthorne, NY
- Brand
- Fluorouracil
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 21 Nov 2012
- FDA classified
- 4 Dec 2012
- Reported
- 12 Dec 2012
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
- Drug class
- Creams, Ointments & Gels
Timeline
| 21 Nov 2012 | Recall initiated by company | |
| 4 Dec 2012 | Classified by FDA | +13 days |
| 12 Dec 2012 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.
Where it was distributed
Nationwide and Puerto Rico
Questions about this recall
Why was it recalled?
Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.
Which lots are affected?
Lot #s: 118903, Exp. March 2013; 119477, 119483, 119743, Exp. May 2013; 119748, June 2013; 110440, Exp. September 2013; 110599, 110602, 110606, 110607, 110949, 110951, 110953, 110954, 110956, 110958, Exp. October 2013; 110962, 110963, 110965, 111659, 111844, Exp. November 2013; 111845, 111846, Exp. December 2013; 112227, 112228, Exp. January 2014.
Where was it sold?
Nationwide and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Taro Pharmaceuticals U
All 36| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Hydrocortisone 1% & Acetic Acid 2% Otic Solution recalled | Taro Pharmaceuticals U | Potency & Assay | NY |
| Drug | CLASS III | Clotrimazole and Betamethasone Dipropionate Cream recalledClotrimazole And Betamethasone Dipropionate | Taro Pharmaceuticals U | Potency & Assay | NY |
| Drug | CLASS I | Clobetasol Propionate Ointment USP, 0.05% tubes recalledClobetasol Propionate | Taro Pharmaceuticals U | Sterility | Nationwide |
| Drug | CLASS II | Nortriptyline HCl Capsules, USP equivalent to 10mg base recalledNortriptyline Hydrochloride | Taro Pharmaceuticals U | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | H-e-b - Athlete's Foot Cream Clotrimazole Cream USP, 1% Anitfungal recalledHEB | Taro Pharmaceuticals U | Potency & Assay | Nationwide |
Other Fluorouracil recalls
All 12| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Fluorouracil 560 MG / IVP recalled by Infusion Options | Infusion Options | Sterility | NY |
| Drug | CLASS II | Fluorouracil 560 MG / IVP Fluorouracil 3340 MG QS 0.9% NACL recalled | Infusion Options | Sterility | NY |
| Drug | CLASS I | Fluorouracil Injection, USP (50 mg / mL) fill in a vial recalledFluorouracil | Fresenius Kabi USA | Particulate Matter | Nationwide |
| Drug | CLASS II | Fluorouracil 4250mg / D5W, Qty recalled by Lincare | Lincare | Sterility | AR |
| Drug | CLASS II | Fluorouracil 4600mg / D5W, Qty recalled by Lincare | Lincare | Sterility | AR |